King TP - Search Results

1

Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.

Safran H, King TP, Choy H, Hesketh PJ, Wolf B, Altenhein E, Sikov W, Rosmarin A, Akerley W, Radie-Keane K, Cicchetti G, Lopez F, Bland K, Wanebo HJ. Safran H, et al. Among authors: king tp. J Clin Oncol. 1997 Mar;15(3):901-7. doi: 10.1200/JCO.1997.15.3.901. J Clin Oncol. 1997. PMID: 9060526 Clinical Trial.

2

p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma.

Safran H, King T, Choy H, Gollerkeri A, Kwakwa H, Lopez F, Cole B, Myers J, Tarpey J, Rosmarin A. Safran H, et al. Cancer. 1996 Sep 15;78(6):1203-10. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1203::AID-CNCR6>3.0.CO;2-A. Cancer. 1996. PMID: 8826941 Clinical Trial.

3

Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.

Safran H, Akerman P, Cioffi W, Gaissert H, Joseph P, King T, Hesketh PJ, Wanebo H. Safran H, et al. Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):53-7. Semin Radiat Oncol. 1999. PMID: 10210540 Clinical Trial.

4

Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu.

Safran H, Iannitti D, Ramanathan R, Schwartz JD, Steinhoff M, Nauman C, Hesketh P, Rathore R, Wolff R, Tantravahi U, Hughes TM, Maia C, Pasquariello T, Goldstein L, King T, Tsai JY, Kennedy T. Safran H, et al. Cancer Invest. 2004;22(5):706-12. doi: 10.1081/cnv-200032974. Cancer Invest. 2004. PMID: 15581051 Clinical Trial.

5

Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma.

Palumbo KS, Wands JR, Safran H, King T, Carlson RI, de la Monte SM. Palumbo KS, et al. Pancreas. 2002 Jul;25(1):39-44. doi: 10.1097/00006676-200207000-00010. Pancreas. 2002. PMID: 12131769

6

A plastid two-pore channel essential for inter-organelle communication and growth of Toxoplasma gondii.

Li ZH, King TP, Ayong L, Asady B, Cai X, Rahman T, Vella SA, Coppens I, Patel S, Moreno SNJ. Li ZH, et al. Among authors: king tp. Nat Commun. 2021 Oct 4;12(1):5802. doi: 10.1038/s41467-021-25987-5. Nat Commun. 2021. PMID: 34608145 Free PMC article.

7

Expression of the Receptor Tyrosine Kinase EphB2 on Dendritic Cells Is Modulated by Toll-Like Receptor Ligation but Is Not Required for T Cell Activation.

Mimche PN, Brady LM, Keeton S, Fenne DS, King TP, Quicke KM, Hudson LE, Lamb TJ. Mimche PN, et al. Among authors: king tp. PLoS One. 2015 Sep 25;10(9):e0138835. doi: 10.1371/journal.pone.0138835. eCollection 2015. PLoS One. 2015. PMID: 26407069 Free PMC article.

8

The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice.

Mimche PN, Brady LM, Bray CF, Lee CM, Thapa M, King TP, Quicke K, McDermott CD, Mimche SM, Grakoui A, Morgan ET, Lamb TJ. Mimche PN, et al. Among authors: king tp. Hepatology. 2015 Sep;62(3):900-14. doi: 10.1002/hep.27792. Epub 2015 Apr 22. Hepatology. 2015. PMID: 25784101 Free PMC article.

9

A vacuolar-H(+) -pyrophosphatase (TgVP1) is required for microneme secretion, host cell invasion, and extracellular survival of Toxoplasma gondii.

Liu J, Pace D, Dou Z, King TP, Guidot D, Li ZH, Carruthers VB, Moreno SN. Liu J, et al. Among authors: king tp. Mol Microbiol. 2014 Aug;93(4):698-712. doi: 10.1111/mmi.12685. Epub 2014 Jul 16. Mol Microbiol. 2014. PMID: 24975633 Free PMC article.

10

Hyaluronidase and hyaluronan in insect venom allergy.

King TP, Wittkowski KM. King TP, et al. Int Arch Allergy Immunol. 2011;156(2):205-11. doi: 10.1159/000322847. Epub 2011 May 19. Int Arch Allergy Immunol. 2011. PMID: 21597301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters